Literature DB >> 18346951

Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.

Karin Hollberg1, Richard Marsell, Maria Norgård, Tobias Larsson, Kenneth B Jonsson, Göran Andersson.   

Abstract

Hypophosphatemic transgenic (tg) mice overexpressing FGF23 in osteoblasts display disorganized growth plates and reduced bone mineral density characteristic of rickets/osteomalacia. These FGF23 tg mice were used as an in vivo model to examine the relation between osteoclast polarization, secretion of proteolytic enzymes and resorptive activity. Tg mice had increased mRNA expression levels of the osteoblast differentiation marker Runx2 and mineralization-promoting proteins alkaline phosphatase and bone sialoprotein in the long bones compared to wild type (wt) mice. In contrast, expression of alpha1(I) collagen, osteocalcin, dentin matrix protein 1 and osteopontin was unchanged, indicating selective activation of osteoblasts promoting mineralization. The number of osteoclasts was unchanged in tg compared to wt mice, as determined by histomorphometry, serum levels of TRAP 5b activity as well as mRNA expression levels of TRAP and cathepsin K. However, tg mice displayed elevated serum concentrations of C-terminal telopeptide of collagen I (CTX) indicative of increased bone matrix degradation. The majority of osteoclasts in FGF23 tg mice lacked ultrastructural morphological signs of proper polarization. However, they secreted both cathepsin K and MMP-9 at levels comparable to osteoclasts with ruffled borders. Mineralization of bone matrix thus appears essential for inducing osteoclast polarization but not for secretion of osteoclast proteases. Finally, release of CTX by freshly isolated osteoclasts was increased on demineralized compared to mineralized bovine bone slices, indicating that the mineral component limits collagen degradation. We conclude that ruffled borders are implicated in acidification and subsequent demineralization of the bone matrix, however not required for matrix degradation. The data collectively provide evidence that osteoclasts, despite absence of ruffled borders, effectively participate in the degradation of hypomineralized bone matrix in rachitic FGF23 tg mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18346951     DOI: 10.1016/j.bone.2008.01.019

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  9 in total

1.  Evaluation of bone markers in hypophosphatemic rickets/osteomalacia.

Authors:  Yuki Nagata; Yasuo Imanishi; Akira Ishii; Masafumi Kurajoh; Koka Motoyama; Tomoaki Morioka; Hiroshi Naka; Katsuhito Mori; Takami Miki; Masanori Emoto; Masaaki Inaba
Journal:  Endocrine       Date:  2011-08-06       Impact factor: 3.633

2.  Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.

Authors:  Liping Xiao; Takahiro Naganawa; Joseph Lorenzo; Thomas O Carpenter; J Douglas Coffin; Marja M Hurley
Journal:  J Biol Chem       Date:  2009-11-20       Impact factor: 5.157

3.  Involvement of SOX-9 and FGF-23 in RUNX-2 regulation in osteoarthritic chondrocytes.

Authors:  Timoklia Orfanidou; Dimitrios Iliopoulos; Konstantinos N Malizos; Aspasia Tsezou
Journal:  J Cell Mol Med       Date:  2009-09       Impact factor: 5.310

4.  Vitamin D Impacts the Expression of Runx2 Target Genes and Modulates Inflammation, Oxidative Stress and Membrane Vesicle Biogenesis Gene Networks in 143B Osteosarcoma Cells.

Authors:  Rama Garimella; Priyanka Tadikonda; Ossama Tawfik; Sumedha Gunewardena; Peter Rowe; Peter Van Veldhuizen
Journal:  Int J Mol Sci       Date:  2017-03-16       Impact factor: 5.923

5.  Excessive dietary intake of vitamin A reduces skull bone thickness in mice.

Authors:  Thomas Lind; Caroline Öhman; Gabriela Calounova; Annica Rasmusson; Göran Andersson; Gunnar Pejler; Håkan Melhus
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

Review 6.  Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption.

Authors:  Hideki Kitaura; Aseel Marahleh; Fumitoshi Ohori; Takahiro Noguchi; Wei-Ren Shen; Jiawei Qi; Yasuhiko Nara; Adya Pramusita; Ria Kinjo; Itaru Mizoguchi
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 5.923

7.  Vitamin a is a negative regulator of osteoblast mineralization.

Authors:  Thomas Lind; Anders Sundqvist; Lijuan Hu; Gunnar Pejler; Göran Andersson; Annica Jacobson; Håkan Melhus
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

8.  Bones in human CYP26B1 deficiency and rats with hypervitaminosis A phenocopy Vegfa overexpression.

Authors:  Thomas Lind; Roberta Lugano; Ann-Marie Gustafson; Maria Norgård; Arie van Haeringen; Anna Dimberg; Håkan Melhus; Stephen P Robertson; Göran Andersson
Journal:  Bone Rep       Date:  2018-06-21

9.  A Sub-Clone of RAW264.7-Cells Form Osteoclast-Like Cells Capable of Bone Resorption Faster than Parental RAW264.7 through Increased De Novo Expression and Nuclear Translocation of NFATc1.

Authors:  Laia Mira-Pascual; Anh N Tran; Göran Andersson; Tuomas Näreoja; Pernilla Lång
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.